Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma

Archives of Neurology

Volumn 67, Issue 3, 2010, Pages 370-372

  Benouaich Amiel, Alexandra ^a   Lubrano, Vincent ^a,b   Tafani, Mathieu ^c,d   Uro coste, Emmanuelle ^d   Gantet, Pierre ^c   Sol, Jean Christophe ^a   Roux, Franck ^a,b   Bousquet, Philippe ^a   Julian, Anne ^c,d   Sabatier, Jean ^a   Tremoulet, Michel ^a   Cances Lauwers, Valerie ^d   Delisle, Marie Bernadette ^d   Clanet, Michel ^a   Esquerré, Jean Philippe ^c,d   Payoux, Pierre ^b,d  

^a CHU PURPAN   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; O (2 FLUOROETHYL)TYROSINE F 18; UNCLASSIFIED DRUG;

ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; GLIOBLASTOMA; GRAY MATTER; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; TYROSINE;

EID: 77749338121     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.22     Document Type: Article

References (15)

1. Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med. 2003; 33(2):148-162.
2. Chen W. Clinical applications of PET in brain tumors. J Nucl Med. 2007;48(9):1468-1481.
3. Wester HJ, Herz M, Weber W, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40(1):205-212.
4. Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot. 2002;57(6):853-856.
5. Pauleit D, Floeth F, Hamacher K, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128(pt 3):678-687.
6. Weber WA, Wester HJ, Grosu AL, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med. 2000;27(5):542-549.
7. Mehrkens JH, Popperl G, Rachinger W, et al. The positive predictive value of O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET in the diagnosis of a glioma recurrence after multimodal treatment. J Neurooncol. 2008;88(1):27-35.
8. Langen K-J, Hamacher K, Weckesser M, et al. O-(2-[18F]fluoroethyl)-L- tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006; 33(3):287-294.
9. Floeth FW, Pauleit D, Wittsack HJ, et al. Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg. 2005;102(2):318-327.
10. Pöpperl G, Goldbrunner R, Gildehaus FJ, et al. O-(2-[18F] fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma. Eur J Nucl Med Mol Imaging. 2005; 32(9):1018-1025.
11. Pöpperl G, Götz C, Rachinger W, Gildehaus FJ, Tonn JC, Tatsch K. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging. 2004;31(11):1464-1470.
12. Popperl G, Gotz C, Rachinger W, et al. Serial O-(2-[(18)F]fluoroethyl)-L- tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging. 2006;33(7):792-800.
13. Pöpperl G, Kreth FW, Herms J, et al. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? J Nucl Med. 2006;47(3):393-403.
14. Pöpperl G, Kreth FW, Mehrkens JH, et al. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading. Eur J Nucl Med Mol Imaging. 2007;34(12):1933-1942.
15. Weckesser M, Langen KJ, Rickert CH, et al. O-(2-[18F]fluorethyl)-L- tyrosine PET in the clinical evaluation of primary brain tumours. Eur J Nucl Med Mol Imaging. 2005;32(4):422-429.